| |
Protocol Number:
90-DK-0137
- Title:
Evaluation of the Gastrinoma in Patients with Zollinger-Ellison Syndrome
- Number:
90-DK-0137
- Summary:
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
- Sponsoring Institute:
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Recruitment Detail
- Type:
No longer recruiting/follow-up only
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
- Special Instructions:
Currently Not Provided
- Keyword(s):
-
Islet Cell Tumors
- Recruitment Keyword(s):
-
None
- Condition(s):
-
Gastrinoma
-
Zollinger Ellison Syndrome
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Interventions:
- None
- Supporting Site:
-
National Institute of Diabetes and Digestive and Kidney Diseases
- Contact(s):
-
This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
- Citation(s):
-
Zollinger-Ellison syndrome: current concepts in diagnosis and management
-
Current diagnosis and management of Zollinger-Ellison syndrome
-
Pathomorphologic, biochemical and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome)
If you have:
Search The Studies | Help | Questions |
Clinical Center Home | NIH Home
 National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 09/15/2008
|
|
